How are the 2025 ESC/EACTS valvular guidelines going to impact my mitral programme?

Francesco Maisano interviews Michael Borger, co-chair of the 2025 ESC/EACS valvular heart disease guidelines, on their practical impact. The updated guidelines emphasize earlier intervention in primary mitral regurgitation, especially for asymptomatic patients with risk factors, while surgery remains preferred for low-risk patients. Michael Borger stresses the importance of a multidisciplinary team approach, high-volume centres for complex cases, and timely, evidence-based interventions to improve patient outcomes. Hosted on Acast. See acast.com/privacy for more information.